Zobrazeno 1 - 10
of 83
pro vyhledávání: '"O B Karyakin"'
Autor:
B P Matveev, O B Karyakin, V B Matveev, Yu G Alyaev, I G Rusakov, A Z Vinarov, B V Bukharkin, L V Shaplygin, B Ya Alekseev, V A Biryukov, S V Galanin, V P Izgeym, A V Lykov, Yu N Khrizman, K Sh Gantsev, P A Karnaukh
Publikováno v:
Современная онкология, Vol 6, Iss 3, Pp 111-113 (2004)
Рак предстательной железы (РПЖ) - одно из наиболее распространенных заболеваний у мужчин пожилого возраста. При наличии костных метаста
Externí odkaz:
https://doaj.org/article/36beef7336064c80815d888dc1b3898c
Autor:
A. V. Troyanov, V. A. Biryukov, I. V. Zaborsky, V. S. Chaykov, I. O. Dementev, E. O. Shchukina, O. B. Karyakin
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 10, Iss 2, Pp 31-39 (2023)
Purpose of the study. Assessment of safety and short‑term effectiveness of high and very high‑risk prostate cancer neoadjuvant chemo‑ hormonal treatment without distant metastases.Patients and methods. Combined hormone chemo‑ radiation treatm
Externí odkaz:
https://doaj.org/article/904626f3e2c243bcbc8b363c47d138a8
Autor:
A. V. Troianov, I. O. Dementev, I. N. Zaborsky, V. S. Chaykov, O. B. Karyakin, Yu. V. Gumenetskaya
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 10, Iss 1, Pp 111-125 (2023)
Purpose of the study. Generalization of the world experience of organ‑preserving treatment in muscle‑invasive bladder cancerMaterials and methods. The literature was searched in Medline, Cochrane Library, Elibrary and PubMed systems. Publications
Externí odkaz:
https://doaj.org/article/e38b07d9e9fa4999ab182ef35c7f00f0
Autor:
I. O. Dementev, K. M. Nyushko, O. B. Karyakin, V. S. Chaikov, A. V. Troyanov, I. N. Zaborskii, E. O. Shchukina
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 8, Iss 3, Pp 97-107 (2021)
Currently, due to the dynamic development of surgical technologies, indications for organ-sparing treatment of kidney cancer are expanding. Acute kidney injury is a serious complication that leads to chronic kidney disease, increased postoperative mo
Externí odkaz:
https://doaj.org/article/48d11c886e954c4bac9d5f8142251b56
Autor:
I. N. Zaborskii, K. N. Safiullin, O. B. Karyakin, S. A. Ivanov, V. S. Chaikov, I. O. Dementev, A. V. Sidorin, G. N. Grishin, A. N. Yurchenko
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 7, Iss 2, Pp 129-143 (2020)
Abstract In recent years, there has been a steady increase in the incidence of bladder cancer (RMP) in our country. So, over the past ten years there has been an increase in the number of cases of primary diagnosis of RMP by more than 1.5 times, whic
Externí odkaz:
https://doaj.org/article/9f88dc42d3ff4023ade34942fd94a53e
Autor:
K. S. Makarova, Yu. V. Gumenetskaya, V. A. Biryukov, A. A. Obukhov, I. A. Strikanova, S. O. Dzhabrailova, O. G. Lepilina, N. B. Borysheva, O. B. Karyakin, S. A. Ivanov, A. D. Kaprin
Publikováno v:
Сибирский онкологический журнал, Vol 18, Iss 2, Pp 15-21 (2019)
Purpose: to analyze toxicity of combined modality radiotherapy in high-risk prostate cancer patients.Material and methods. Short-term outcomes after combined modality radiotherapy were analyzed in 88 prostate cancer patients treated at clinic of the
Externí odkaz:
https://doaj.org/article/facfcd3c51244dd79335b21d6c277cc0
Autor:
K. S. Makarova, Yu. V. Gumenetskaya, V. A. Biryukov, T. A. Rodina, A. B. Galitsyna, E. O. Shchukina, O. B. Karyakin, S. A. Ivanov, A. D. Kaprin
Publikováno v:
Cancer Urology. 19:76-84
Background. Currently, the group of intermediate risk prostate cancer (PC) includes 2 subgroups - favorable and unfavorable intermediate risk according to the National Comprehensive Cancer Network (NCCN) classification. The optimal scope of therapy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02a975a2621952ef8e76b0ad2b3904f8
https://doi.org/10.17650/1726-9776-2023-19-1-76-84
https://doi.org/10.17650/1726-9776-2023-19-1-76-84
Autor:
V. S. Chaykov, I. O. Dementyev, O. B. Karyakin, E. O. Shchukina, A. V. Troyanov, S. A. Ivanov, A. D. Kaprin
Publikováno v:
Cancer Urology. 19:25-34
Background. Renal cell carcinoma is one of the most common urologic cancers. Due to development of modern diagnostic methods, kidney tumors are often diagnosed at early stages (cT1a-T1b). The golden standard of treatment of localized renal cell carci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::670d74c2d0bd6c6f21f35095066d4e6d
https://doi.org/10.17650/1726-9776-2023-19-1-25-34
https://doi.org/10.17650/1726-9776-2023-19-1-25-34
Autor:
O. B. Karyakin
Publikováno v:
Cancer Urology. 18:141-146
This review presents the main lines of research on bladder cancer in 2021 and 2022. The review largely focuses on molecular studies in the context of primary diagnosis and disease progression. Based on molecular and genetic data, 3 main types of blad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4455c6a02586cbbfe88af47408e71ddc
https://doi.org/10.17650/1726-9776-2022-18-4-141-146
https://doi.org/10.17650/1726-9776-2022-18-4-141-146
Autor:
V. V. Krylov, N. S. Legkodimova, T. Yu. Kochetova, V. M. Petriev, M. A. Sigov, V. K. Tishchenko, A. I. Pronin, A. Yu. Shurinov, K. M. Petrosyan, O. N. Spichenkova, O. B. Karyakin, V. A. Biryukov, V. F. Stepanenko, O. P. Vlasova, P. V. Shegaj, S. A. Ivanov, A. D. Kaprin
Publikováno v:
Diagnostic radiology and radiotherapy. 13:75-85
INTRODUCTION: The results of studies of clinical potential of a new domestic radiopharmaceutical 177Lu-DOTA-PSMA in patients with metastatic castration-resistant prostate cancer are presented in this article.OBJECTIVE: The pharmacokinetics, safety an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdb57b61a11e365eb7351e7acaa6c859
https://doi.org/10.22328/2079-5343-2022-13-4-75-85
https://doi.org/10.22328/2079-5343-2022-13-4-75-85